A Dallas-based biotech company called Colossal Biosciences says it has produced “de-extinct” dire wolf pups using gene-editing technology, but critics argue the animals are genetically modified gray ...
Tools like CRISPR-Cas9 are creating new opportunities for innovation in St. Louis, as well as risks around IP protection and regulation.
A Dallas-based startup says it has produced three “de-extinct” dire wolf pups using gene-editing technology — and the dodo and woolly mammoth are next. But the gap between the company’s marketing and ...
Barclays 28th Annual Global Healthcare Conference March 12, 2026 8:30 AM EDTCompany ParticipantsAmy Parison - Senior VP ...
Key opportunities in Saudi Arabia's synthetic biology market include leveraging government investments and biotechnology advancements driven by Vision 2030. The focus is on reducing oil dependence by ...
Colossal Biosciences’ CEO says its work follows a ‘moral obligation’ while critics say it’s ‘tech bro’ hype that could undermine conservation ...
Organizaciones instan a participar en consulta pública sobre nuevas técnicas genéticas y trigo editado Warnings are issued regarding ...
Animal Genetics Market OverviewThe Animal Genetics Market is anticipated to grow at a CAGR of 6–7% between 2023 and 2028. This upward trajectory is driven by several influential factors, including the ...
Detailed price information for Intellia Thera CS (NTLA-Q) from The Globe and Mail including charting and trades.
In order to discuss this topic further, pharmaphorum spoke with Sheila Diamond, director of scientific engagement at Medidata ...
In April of 2025, headlines across the world announced that the dire wolf had been brought back from extinction. This 130-150 lbs wolf species, about 25% heavier than modern-day gray wolves, had not ...
In Michigan Tech's biology teaching lab, undergraduate students research potential cancer cures with help from the humble worm.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results